RxDoctor Payments DataLook up a doctor →

Sergei Belenky

Allergy & Immunology · Pittsburgh, PANPI 1750373171

Payments from drug & device makers

$774,645in general payments, 2019–2025

Across 1,208 payments — averaging $641.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$241K
  • Sanofi$226K
  • Regeneron Healthcare Solutions, Inc.$157K
  • AstraZeneca$40K
  • Genentech USA, Inc.$25K
  • Pfizer$18K
  • plus $67K from 39 others

What the payments were for

  • Consulting fees$27,7624%
  • Speaking & faculty fees$641,37683%
  • Travel & lodging$66,1119%
  • Food & beverage$39,1655%
  • Education$2310%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$774,645 in reported general payments places this provider in the 95th percentile of 175 allergy & immunology providers in Pennsylvania.

See all allergy & immunology providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$8,461
Pantoprazole Sodium11$101
Montelukast Sodium12$13

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere$40,402$8,46114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 175 allergy & immunology providers in Pennsylvania.

Other allergy & immunology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →